Evaluation of the Effect of a Concurrent Chronic Total Occlusion on Long-Term Mortality and Left Ventricular Function in Patients After Primary Percutaneous Coronary Intervention
Bimmer E.P.M. Claessen, MD,
René J. van der Schaaf, MD,
Niels J. Verouden, MD,
Nienke K. Stegenga, MSc,
Annemarie E. Engstrom, MD,
Krischan D. Sjauw, MD,
Wouter J. Kikkert, MD,
Marije M. Vis, MD,
Jan Baan, Jr, MD, PhD,
Karel T. Koch, MD, PhD,
Robbert J. de Winter, MD, PhD,
Jan G.P. Tijssen, PhD,
Jan J. Piek, MD, PhD,
José P.S. Henriques, MD, PhD*
Department of Cardiology, Academic Medical Center–University of Amsterdam, Amsterdam, the Netherlands
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Landmark Survival Analysis
Cumulative risk of death during the first 30 days after primary percutaneous coronary intervention (PCI) and thereafter for patients with single-vessel disease (SVD), multivessel disease (MVD), and a chronic total occlusion (CTO).
|
|
View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Proportion of Patients With LVEF <40% After ST-Segment Elevation Myocardial Infarction
LVEF = left ventricular ejection fraction; Pts = patients; other abbreviations as in Figure 1.
|
|
|
